Tokyo, June 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061812) titled 'An Epidemiological Study of Skin Characteristics in Adult Women' on June 6.

Study Type: Observational

Primary Sponsor: Institute - DRC

Condition: Condition - Helthy skin Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study will be conducted in 200 adult women, involving various photographic assessments and instrumental measurements. The results obtained will be used to support the design and optimization of cosmetics, quasi-drugs, and health foods, as well as the development of novel skin evaluation methods and assessment devices. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old = Gender - Female Key inclusion criteria - Women aged 20 years or older and under 60 years at the time of informed consent (target: approximately 50 subjects per age group) Healthy female subjects Subjects who have received sufficient explanation regarding the purpose and procedures of the study, possess the capacity to provide consent, fully understand the study, voluntarily agree to participate, and are able to provide written informed consent Key exclusion criteria - Subjects with any condition at the evaluation site that may affect study results (e.g., urticaria, inflammation, eczema, wounds, acne, warts, pigmentation, or residual marks); those with a past or current history of atopic dermatitis or atopic predisposition (including family history); those who have received or plan to receive cosmetic medical procedures at the evaluation site (e.g., botulinum toxin, fillers, photofacial); those who have undergone or plan to undergo special skincare treatments (e.g., aesthetic/salon treatments) within 4 weeks; those who have changed or newly started health foods, skincare products, or sunscreen within 4 weeks; those with excessive UV exposure beyond daily life within 4 weeks or planned during the study; night shift or rotating shift workers; those receiving medical treatment at the time of consent or judged to require treatment; those with severe systemic diseases (metabolic, hepatic, renal, cardiovascular, respiratory, endocrine, immune, neurological); those with a history of alcohol or drug dependence; those at risk of allergy to cosmetics or foods (including skin reactions within 1 year); those who are pregnant, breastfeeding, or planning pregnancy; those who participated in other human studies within 4 weeks or plan to participate during the study; and those deemed unsuitable by the investigator. Target Size - 200

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 04 Month 10 Day Date of IRB - 2026 Year 05 Month 14 Day Anticipated trial start date - 2026 Year 06 Month 06 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070733

Disclaimer: Curated by HT Syndication.